We have issued an updated research report on Colfax Corporation on Jul 11.
The company currently carries a Zacks Rank #5 (Strong Sell). Its market capitalization is approximately $3.1 billion.
Let’s delve deeper and discuss what led to its poor investment appeal.
Share Price Performances & Earnings Estimate Revision: Market sentiments have been against Colfax for quite some time now. Its stock price has decreased roughly 14.1% in the past three months compared with the industry’s decline of 1.4%.
Also, it is worth noting that shares of the company have lost 3% since the release of first-quarter 2019 results on May 8, 2019. Furthermore, earnings estimates for the company for 2019 and 2020 have been lowered in the past 60 days. Currently, the Zacks Consensus Estimate for its earnings is pegged at $2.58 for 2019 and $2.61 for 2020, reflecting declines of 0.4% and 11.2% from the respective 60-day-ago numbers.
Colfax Corporation Price and Consensus
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
We have issued an updated research report on Colfax Corporation on Jul 11.
The company currently carries a Zacks Rank #5 (Strong Sell). Its market capitalization is approximately $3.1 billion.
Let’s delve deeper and discuss what led to its poor investment appeal.
Share Price Performances & Earnings Estimate Revision: Market sentiments have been against Colfax for quite some time now. Its stock price has decreased roughly 14.1% in the past three months compared with the industry’s decline of 1.4%.
Also, it is worth noting that shares of the company have lost 3% since the release of first-quarter 2019 results on May 8, 2019. Furthermore, earnings estimates for the company for 2019 and 2020 have been lowered in the past 60 days. Currently, the Zacks Consensus Estimate for its earnings is pegged at $2.58 for 2019 and $2.61 for 2020, reflecting declines of 0.4% and 11.2% from the respective 60-day-ago numbers.
Colfax Corporation Price and Consensus
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on ROP - FREE
Get the latest research report on GTLS - FREE